• Tue, April 15, 2025
  • Wed, April 16, 2025
  • Thu, April 17, 2025
  • Fri, April 18, 2025
  • Sat, April 19, 2025
  • Sun, April 20, 2025
  • Mon, April 21, 2025

Pfizer discontinues its experimental GLP-1 pill

Biotech news stories of the day, brought to you by The Readout.
The article from STAT News dated April 14, 2025, discusses several significant developments in the biotech industry. Pfizer is reportedly in discussions to acquire a company focused on developing a GLP-1 pill for weight loss, reflecting the growing interest in obesity treatments. Verve Therapeutics announced positive results from a clinical trial of its gene-editing therapy aimed at reducing cholesterol levels, marking a potential breakthrough in cardiovascular disease management. Additionally, the National Institutes of Health (NIH) has launched a new initiative to expand the use of CRISPR technology in medical research, aiming to accelerate the development of new treatments. These updates highlight the dynamic and rapidly evolving landscape of biotechnology, with a focus on innovative therapies for major health issues.

Read the Full STAT Article at:
https://www.statnews.com/2025/04/14/biotech-news-pfizer-verve-nih-crispr-glp-1-pill-cholesterol-the-readout/